Galera Therapeutics(GRTX.US)

Last Updated 19:00:00 ET
longbridge loading

Galera Therapeutics Expands Share Authorization, Enhances Stockholder Rights

Tip Ranks·
US
GRTX
-0.89%
Tip Ranks·
US
GRTX
-0.89%

Galera Therapeutics | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
GRTX
-0.89%
Earnings Watch·
US
GRTX
-0.89%

Assertio Holdings shares are trading higher after the company announced it entered into an Amended and Restated Agreement and Plan of Merger with Garda Therapeutics pursuant to which Garda has increased its offer to acquire all outstanding shares of Assertio to $21.80 per share in cash with no contingent value right.

benzinga_article·
US
ASRT
+0.17%
US
GRTX
-0.89%
benzinga_article·
US
ASRT
+0.17%
US
GRTX
-0.89%

13:27 ET$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--LEG, AVNS, GRTX, and GSAT

prnewswire·
US
GRTX
-0.89%
US
GSAT
+0.60%
US
LEG
+5.25%
prnewswire·
US
GRTX
-0.89%
US
GSAT
+0.60%
US
LEG
+5.25%

Weight-loss drugs developer Kailera surges 62.5% in Nasdaq debut

fidelity·
US
GRTX
-0.89%
US
BBH
+0.68%
US
IBB
+1.83%
fidelity·
US
GRTX
-0.89%
US
BBH
+0.68%
US
IBB
+1.83%

Kailera Therapeutics Announces Pricing of Initial Public Offering | KLRA Stock News

StockTitan·
US
KPTI
+4.69%
US
NBSE.ESC
0.00%
US
GRTX
-0.89%
StockTitan·
US
KPTI
+4.69%
US
NBSE.ESC
0.00%
US
GRTX
-0.89%

Obsidian Therapeutics To Merge With Galera In Reverse Merger

rttnews·
US
GRTX
-0.89%
US
ARKG
+4.20%
US
LABU
+10.83%
rttnews·
US
GRTX
-0.89%
US
ARKG
+4.20%
US
LABU
+10.83%
© 2026 Longbridge｜Disclaimer